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The aim of this experiment was to investigate the effect of 17𝛽-estradiol on cutaneous wound healing in 12-week ovariectomized
(OVX) female mice. Eight-week-old female mice were divided into three groups: administration of 17𝛽-estradiol after OVX (OVX
+ 17𝛽-estradiol), OVX, and sham (SHAM). Four weeks after surgery, the mice received two full-thickness cutaneous wounds. 17𝛽-
Estradiol at 0.01 g/daywas administered on the backs ofmice in theOVX+ 17𝛽-estradiol group every day. Plasma 17𝛽-estradiol level
in the OVX + 17𝛽-estradiol group was thus significantly higher than in the SHAM and OVX groups, but there was no significant
difference between SHAM and OVX groups. The ratio of wound area was not significantly different among the three groups.
However, the period required to reach a ratio of wound area of 0.15 in the OVX + 17𝛽-estradiol group was significantly shorter
than in the SHAM and OVX groups. These results indicate that cutaneous wound healing in young OVX mice was promoted by
the administration of 17𝛽-estradiol compared with that in SHAM and OVX mice without such administration, but there was no
difference between the latter two groups that did not differ in 17𝛽-estradiol level.
1. Introduction
Cutaneous wound healing is a complex tightly orchestrated
response to injury, carefully regulated at temporal and spatial
levels [1]. With advanced age in humans and rodents, this
series of events becomes disrupted and healing is delayed [2–
4].
Recently, it has come to light that this series of events
is also disrupted by estrogenic sex steroids in the healing of
acute cutaneous wounds [5]. In young female rodents, that
had undergone ovariectomy (OVX), cutaneous wound heal-
ing was delayed by systemic reduced estrogen compared with
that in SHAM [6–15], whereas exogenous estrogen treatment
reversed this delay by decreasingwound area [6–15], reducing
local production of the inflammatory cells neutrophils or
macrophages [7–11, 13], as well as the proinflammatory
cytokine TNF-𝛼 [7–11], and promoting reepithelialization
[8, 10–13] and collagen deposition [6]. Therefore, previous
research suggested that estrogen promotes cutaneous wound
healing in OVX female rodents by several effects.
However, previous work evaluating the effect of estrogen
used only 8- to 10-week-old female mice, and, to the best
of our knowledge, no research using aged female mice has
been presented. Therefore, we investigated the effect of 17𝛽-
estradiol on cutaneous wound healing using 24-week OVX
female mice [16]. We clarified that exogenous and con-
tinuous 17𝛽-estradiol administration promoted cutaneous
wound healing in 24-week OVX female mice by reducing
wound area, shortening the inflammatory response, and
promoting wound contraction more than in mice with OVX
alone. In addition, no parameters in our previous research
showed significant differences between SHAM and OVX
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mice. Moreover, although previous research reported that
plasma 17𝛽-estradiol level in OVX rodents was lower than
that in SHAM rodents [17, 18], our previous study showed
that plasma 17𝛽-estradiol levels between SHAM and OVX
mice were not significantly different [16]. Therefore, the aim
of this research was to clarify whether the wound healing of
young female mice that undergo OVX at 8 weeks old and are
wounded at 12 weeks old differs from that of SHAMmice.
2. Materials and Methods
2.1. Animals. Forty-two C57BL/6 female mice aged 7 weeks
(Sankyo Lab Service Co., Tokyo, Japan) were used in
this experiment. They were caged individually in an air-
conditioned room at 25 ± 2.0∘C with light from 08:45 to
20:45 hours, and water and chow were given freely. All
animal experiments conducted in this study were reviewed
and approved by Kanazawa University Animal Experiment
Committee and carried out in accordancewith theGuidelines
for the Care and Use of Laboratory Animals of Kanazawa
University, Japan (AP-091208).
2.2. Wounding. The mice were bred for 1 week. At this time,
they were anesthetized by intraperitoneal (IP) injection of
pentobarbital sodium (0.05mg/g weight), and the dorsum
was shaved. Then, they were subjected to sham surgery
(SHAM) or ovariectomy (OVX) according to the OECD
guidelines [19]. Four weeks later, they were divided into three
groups: SHAM group, OVX group, and OVX + 17𝛽-estradiol
group. Then, under anesthesia with shaving, two circular
full-thickness skin wounds (4mm in diameter) including the
panniculus carnosus muscle on both sides of the dorsum of
the mouse were made with a Kai sterile disposable biopsy
punch (Kai Industries Co. Ltd., Gifu, Japan). In the SHAM
andOVXgroups, thewoundswere coveredwith hydrocolloid
dressings (Tegaderm; 3M Health Care, Tokyo, Japan) to
maintain a moist environment, and then the mouse was
wrapped with sticky bandages (Meshpore Tape; Nichiban,
Tokyo, Japan), which were changed every day. In the OVX
+ 17𝛽-estradiol group, wounds received the same treatment.
However, after wound treatment, they were also treated with
0.01 g of 17𝛽-estradiol gel (L’estrogel 0.06%; Bayer Yakuhin,
Osaka, Japan). It was placed onwrap filmusing a 1mL syringe
and applied to the back skin avoiding the wounds every
day. We performed a preliminary experiment on the dose of
17𝛽-estradiol. In this experiment, 0.01 g, 0.02 g, and 0.05 g of
17𝛽-estradiol gel were administered to each OVX mice and
wound area was measured for 15 days. In terms of the results,
wound area did not significantly differ among the doses. In
addition, plasma 17𝛽-estradiol level in the mice with OVX
and administration of 0.01 g of 17𝛽-estradiol was significantly
greater than that of the mice with OVX alone. Therefore, we
selected 17𝛽-estradiol administered at a dose of 0.01 g in our
experiment.
2.3. Macroscopic Observation. The day when wounds were
made was designated as day 0, and the process of wound
healing was observed from days 0 to 21. Wound edges were
traced on polypropylene sheets and photographs were taken
every day. The traces on the sheets were captured with a
scanner onto a personal computer using Adobe Photoshop
Elements 7.0 (Adobe System Inc., Tokyo, Japan), and the areas
of wounds were calculated using the image analysis software
Scion Image Beta 4.02 (Scion Corporation, Frederick, MD,
USA).
2.4. Plasma 17𝛽-Estradiol Assay. The mice were euthanized
by pentobarbital sodium IP injection on day 20. Plasma
was prepared from each mouse’s blood isolated through
cardiac puncture and frozen until the time of assay. Plasma
17𝛽-estradiol level was determined by radioimmunoassay
(RIA). This was outsourced to the manufacturer of this assay
(Mitsubishi Chemical Medience Corporation, Tokyo, Japan).
2.5. Vaginal Smears. Vaginal smears were carried out for 7
days before wounding in the SHAM and OVX groups. In the
OVX + 17𝛽-estradiol group, they were performed for 7 days
before and after wounding. A cotton wool tip was moistened
by dipping into saline. The tip of the swab stick was inserted
carefully into the mouse’s vagina with rotation of the swab.
Then, the tip was rolled on a glass slide. The samples were
fixed in 100% alcohol and stainedwith hematoxylin and eosin
(H-E). Images were imported onto a computer using a digital
microscopic camera (DP2-BSW Olympus, Japan).
2.6. Histological Procedure and Microscopic Observation. The
mice were euthanized by the injection of a lethal dose of
pentobarbital sodium IP on days 7, 11, and 15 after wounding.
The wound and the surrounding intact skin were harvested.
They were stapled onto polypropylene sheets to prevent
overcontraction and fixed in zinc fixative (BD Pharmingen,
Tokyo, Japan) for 24 hours.Then, thewound and surrounding
intact skin were bisected at the wound center. The samples
were dehydrated in an alcohol series, cleaned in xylene, and
embedded in paraffin to prepare 5 𝜇m serial paraffin sections.
The sections of 5 𝜇m thickness were stained withH-E. Images
were imported onto a computer using a digital microscopic
camera (DP2-BSW Olympus, Japan).
2.7. Statistical Analysis. Data are expressed as mean ± SD,
analyzed using JMP 8.0.1 (SAS, USA). ANOVA or Tukey-
Kramermultiple comparison test was performed. Differences
were considered significant at 𝑃 < 0.05.
3. Results
3.1. Plasma 17𝛽-Estradiol Levels. We confirmed that the ova-
ries had been removed successfully in the OVX and OVX +
17𝛽-estradiol groups.All of themice hadplasma 17𝛽-estradiol
levels under 10 pg/mL in the SHAM group, while 12/13 mice
had levels under 10 pg/mL and the other mouse had a level of
17 pg/mL in theOVX group.On the other hand, in theOVX+
17𝛽-estradiol group, only 3/13 mice had plasma 17𝛽-estradiol
levels under 10 pg/mL, while the remaining 10 mice with
levels over 10 pg/mL had a mean of 17.2 ± 5.8 pg/mL. Plasma
17𝛽-estradiol levels in the OVX + 17𝛽-estradiol group were
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Figure 1: Macroscopic wound healing. (a) Four mm diameter wounds were inflicted and healing was recorded by photography. Bar, 4mm.
(b) Ratios of wound areas to the initial area on day 0 are shown on line graphs for each day. There were no significant differences among the
three groups. Values are expressed as mean ± SD, 𝑛 = 10 for each group.
significantly higher than those in the SHAMandOVXgroups
(𝑃 < 0.0001 and 0.0002, resp.). However, there were no
significant differences between the SHAM and OVX groups.
3.2. Vaginal Smears. In the SHAM group, four different
figures, proestrus, estrus, metestrus, and diestrus, were
observed for 7 days before wounding. In the OVX group,
diestrus with leukocytes was maintained for 7 days before
wounding. In the OVX + 17𝛽-estradiol group, estrus with
cornified squamous epithelial cells was maintained for 7 days
after wounding.
3.3. Wound Area. In the SHAM group, wound areas rapidly
increased for 4 days and then peaked (1.81 ± 0.36, ratio of
wound area to initial wound area on day 4 after wound-
ing). They subsequently decreased rapidly until day 13 after
wounding (0.34 ± 0.18, ratio of wound area to initial wound
area on day 13 after wounding), after which they decreased
slowly until day 20 afterwounding (0.15± 0.07, ratio of wound
area to initial wound area on day 20 after wounding). In
the OVX group, wound areas rapidly increased for 4 days
and peaked at days 4 to 6 after wounding (1.71 ± 0.30 to
1.71 ± 0.31, ratio of wound area to initial wound area on days
4 to 6 after wounding). Then, they decreased rapidly until
day 15 after wounding (0.27 ± 0.21, ratio of wound area to
initial wound area on day 15 after wounding), after which they
decreased slowly until day 20 after wounding (0.15 ± 0.09,
ratio of wound area to initial wound area on day 20 after
wounding). On the other hand, in the OVX + 17𝛽-estradiol
group, wound area rapidly increased for only 3 days and then
peaked (1.72±0.31, ratio of wound area to initial wound area
on day 3 afterwounding), afterwhich it decreased slowly until
day 6 after wounding. Then, it decreased rapidly until day 14
after wounding (0.18 ± 0.17, ratio of wound area to initial
wound area on day 14 after wounding) and slowly again until
day 16 after wounding (0.10 ± 0.07, ratio of wound area to
initial wound area on day 16 after wounding), after which
the wound area was almost unchanged until day 20 after
wounding (0.09 ± 0.07, ratio of wound area to initial wound
area on day 20 after wounding).
There were no significant differences among the three
groups on days 0–20. However, the mean ratio of wound area
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in theOVX+ 17𝛽-estradiol groupwas smaller throughout the
whole period, except for days 0–4 (Figure 1(b)).
3.4. Period Required to Reach Ratio of Wound Area of 0.15.
When wounds healed and formed a scar, the mean ratio
of the wound area relative to the original size reached 0.15.
For example, wounds on day 18 in the SHAM and OVX
groups, and on day 14 or day 16 in the OVX + 17𝛽-estradiol
group, showed a scar (Figure 1(a)). We calculated the period
required to reach a ratio of wound area of 0.15 for each group.
These periods were 18.0 ± 1.83 days in the SHAM group,
19.1±3.0 days in the OVX group, and 14.0 ± 2.86 days in the
OVX+ 17𝛽-estradiol group (Figure 2), with that of theOVX+
17𝛽-estradiol group being significantly shorter than those of
the other two groups (𝑃 = 0.0005 for both). However, there
was no significant difference between the SHAM and OVX
groups (Figure 2).
3.5. Microscopic Findings. On day 7, after wounding, wound
width was almost the same among the three groups. On the
other hand, progression of reepithelialization in the OVX +
17𝛽-estradiol group seemed to occur faster than in the SHAM
and OVX groups (Figures 3(a), 3(c), and 3(e)).
Onday 11, afterwounding,woundwidth, that is, thewidth
of the granulation tissue of the center of the wound, in the
OVX + 17𝛽-estradiol group seemed to be shorter than that
in the SHAM and OVX groups. New epithelium completely
covered the wound surface in the three groups.
On day 15, after wounding, the widths of wounds in all
groups were shorter than those on day 11.
4. Discussion
In this study, vaginal smears in the OVX + 17𝛽-estradiol
group showed that estrus with cornified squamous epithelial
cells was maintained for 7 days after wounding and plasma
17𝛽-estradiol levels in the OVX + 17𝛽-estradiol group were
significantly higher than those in the SHAM and OVX
groups.However, in the SHAMandOVXgroups, plasma 17𝛽-
estradiol levels were almost always under 10 pg/mL. These
results show that 17𝛽-estradiol administered percutaneously
was sufficiently absorbed. On the other hand, although estrus
cycle was not observed in the OVX group, but in the SHAM
group, plasma 17𝛽-estradiol levels were not significantly
different between these two groups. Moran et al. reported
that the plasma 17𝛽-estradiol level of OVX mice was under
10 pg/mL [18].Nelson et al. reported that this level was around
20–30 pg/mL in the proestrus state [20], while Walmer et
al. reported that it increased and peaked in the proestrus
state [21]. However, Haisenleder et al. reported that plasma
17𝛽-estradiol levels in SHAM and OVX groups were almost
always under 10 pg/mL [22] and our previous study reported
that plasma 17𝛽-estradiol levels showed no significant differ-
ences between SHAM and OVX mice [16]. Comparing these
findings with our study, it cannot necessarily be said that the
level of 17𝛽-estradiol in SHAMmice is always higher than that






































































Figure 2: Period required to reach a ratio of wound area of 0.15.The
period required to reach this ratio in the OVX + 17𝛽-estradiol group
was significantly shorter than that in the SHAM and OVX groups.
However, there were no significant differences between the SHAM
and OVX groups. Values are expressed as mean ± SD, 𝑛 = 10 for
each group, ANOVA, Tukey-Kramer. ∗∗𝑃 < 0.01: versus the OVX +
17𝛽-estradiol group.
of 17𝛽-estradiol shows a difference depending on age in future
work.
In this study, although the ratio of wound area relative
to the original size in the OVX + 17𝛽-estradiol group was
not significantly different from those in the SHAM and OVX
groups, the periods required to reach a ratio of wound area
of 0.15 in the OVX + 17𝛽-estradiol group were significantly
shorter than those in the SHAM and OVX groups. Previous
research reported that exogenous estrogen treatment pro-
moted cutaneous wound healing in 8–10-week OVX female
mice by decreasing wound area [6–15]. Our previous study
also reported that exogenous and continuous 17𝛽-estradiol
administration promoted cutaneous wound healing in 24-
week OVX female mice by decreasing wound area, and
plasma 17𝛽-estradiol level in OVX + 17𝛽-estradiol mice was
significantly higher than that in OVX mice [16]. In the
present work, plasma 17𝛽-estradiol level in the OVX + 17𝛽-
estradiol group was also significantly higher than those in
the SHAM and OVX groups. These findings indicate that
cutaneous wound healing in youngmice was promoted when
a high level of 17𝛽-estradiol was administered in OVX mice,
compared with those in SHAM mice and mice with OVX
alone.
On the other hand, the ratio of wound area was not
significantly different between the SHAM and OVX groups
on days 0–20 and the transition of the ratio of wound areawas
almost the same in these two groups. Many previous studies
reported that wound area in 8–10-week OVX mice was
significantly larger than that in SHAMmice [6–15], although
none of these previous studies reported the reproductive
status. Calvin et al. reported that the ratio of wound area was













Figure 3: Hematoxylin and eosin staining of sections on day 7. (a) Section of the SHAM group. Bar, 500 𝜇m. (b) Enlargement of the square in
(a). Bar, 50 𝜇m. (c) Section of the OVX group. Bar, 500 𝜇m. (d) Enlargement of the square in (c). Bar, 50 𝜇m. (e) Section of the 17𝛽-estradiol
group. Bar, 500 𝜇m. (f) Enlargement of the square in (e). Bar, 50 𝜇m. Arrows indicate wound edges and arrowheads indicate the tip of new
epithelium.
not significantly different between SHAM and OVX rodents,
when using 9-week female Wistar rats [23]. We estimated
from a graph in this previous report that the plasma 17𝛽-
estradiol level in the OVX rats was 28 pmol/L (7.63 pg/mL)
and 50 pmol/L (13.6 pg/mL) in SHAM rats. Moreover, our
previous study reported that the ratio of wound area and
plasma 17𝛽-estradiol level were not significantly different
between SHAM and OVX mice at 24 weeks of age [16].
In the present study, plasma 17𝛽-estradiol level was also
not significantly different between SHAM and OVX groups.
Therefore, it is estimated that cutaneous wound healing in
young mice showed no difference between SHAM and OVX
mice when the level of 17𝛽-estradiol was almost the same.
That is, it is thought that themodel of ovariectomy carried out
on a young female mouse does not necessarily directly reflect
the status of a menopausal woman. Therefore, we plan to
investigate the effect of estrogen on cutaneous wound healing
and its mechanism by using mouse models at an advanced
age.
5. Conclusions
Our study showed that cutaneous wound healing in young
mice was promoted by administration of a high level of 17𝛽-
estradiol in OVX mice compared with the levels in SHAM
mice andmicewithOVXalone, but cutaneouswoundhealing
showed no difference between these latter two groups that
had similar levels of 17𝛽-estradiol although previous research
reported that cutaneous wound healing in OVX mice was
delayed compared with that in SHAMmice.
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